International Journal of Cancer Care and Delivery
A Single-Center Analysis of Pathologic and Clinical Features, Treatment, and Outcomes in Post-Transplant Lymphoproliferative Disorder (PTLD)
By Elisa De Togni, Connor Hartzell, Emily Mason and 3 others.
Abstract
BackgroundPTLD is a rare heterogenous group of lymphoproliferative diseases arising from chronic immunosuppression after solid organ or allogeneic stem cell transplantation (allo-SCT).Treatment of PTLD involves a sequential approach with immunosuppression reduction and chemoimmunotherapy.
Keywords
- Viral-associated cancers and disorders
- Open access
Source
Published in International Journal of Cancer Care and Delivery. The abstract is shown as published and remains the work of its authors; read the full article at the source.
Prognia lists this article for reference and education. It is not medical advice. Always read the original and follow current guidelines and local protocols before acting on it.